What exactly did Morgan Stanley change on Feb 13, 2026 for CW?

Morgan Stanley maintained an **Overweight** rating and raised the **CW price target to $760** from $660 on Feb 13, 2026. The firm kept its positive view but signaled higher expected upside tied to defense backlog and margin recovery.

How should investors interpret the CW analyst rating now?

The CW analyst rating remaining Overweight signals continued analyst confidence. Investors should weigh the **$760** target against current price, company guidance, and execution on 2026 EPS growth before acting.

Does the Morgan Stanley move count as an upgrade or downgrade for Curtiss-Wright?

No. Morgan Stanley’s action is a maintained positive stance. It is not an upgrade or a downgrade, but the raised price target increases implied upside while keeping the same rating.

Where can I read the Morgan Stanley note and related coverage?

Public summaries of the note appear on TheFly and MarketWatch. See TheFly for the initial permalinks summary and MarketWatch for broader market context.

Analyst Ratings

Morgan Stanley Maintains Overweight on Curtiss-Wright (CW) Feb 13, 2026

ByDanny Kontos February 16, 2026February 16, 2026

Morgan Stanley maintained an Overweight rating on Curtiss-Wright Corporation (CW) on February 13, 2026. The CW analyst rating stayed positive as Morgan Stanley raised its price target to $760 from $660. Morgan Stanley cited stronger defense backlog and margin improvement as reasons for the move. This note is the only analyst action tracked on Feb 13, 2026 and it links a higher target to expected 2026 EPS growth.